Revenue grew 3.5% to CHF 582.7 million and EBIT margin improved to 13.0%, driven by strong Healthcare performance and ongoing transformation. Industrial division faced subdued demand, but overall profitability and ROCE increased. Capsul'Invest acquisition and transformation program advanced as planned.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.